Telmisartan Tanks in Lower Extremity Peripheral Artery Disease
The angiotensin II receptor blocker (ARB) telmisartan (Micardis) did not significantly improve walking performance in patients with lower-extremity peripheral artery disease (PAD) in a randomized […]
Read more